Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiation protectants: current status and future prospects.

Thomas M Seed1

  • 1VSL Physics, Hannon Hall, Room 408, Catholic University of America, 620 Michigan Avenue NE, Washington, DC 20064, USA. seed@vsl.cua.edu

Health Physics
|October 12, 2005
PubMed
Summary

Developing new radioprotective agents is crucial for public health in a high-threat environment. Current research explores various strategies to find safe and effective oral medications for radiation protection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative study of pathology of various organs of rhesus macaques exposed to two different doses of acute total-body radiation.

Scientific reports·2026
Same author

Cutting-edge animal models for radiation combined injury drug development.

Expert opinion on drug discovery·2025
Same author

Development of PLX-R18, a promising and novel countermeasure for radiation-associated injuries.

Drug discovery today·2025
Same author

Characterization of rhesus macaque model for cobalt-60 gamma-radiation source without use of blood product.

Scientific reports·2025
Same author

New opportunities and current challenges using animal models for the discovery of novel countermeasures for acute radiation syndrome.

Expert opinion on drug discovery·2025
Same author

Comparison of sensitivity of rhesus and cynomolgus macaque for acute radiation effects.

Scientific reports·2025

Area of Science:

  • Radiation Biology
  • Pharmacology
  • Public Health

Background:

  • Increased global threats necessitate effective radioprotective agents for both special groups and the general population.
  • Existing radioprotective drugs like Amifostine have limitations including toxicity and administration routes, hindering widespread use.
  • The ideal radioprotective agent remains elusive, requiring novel approaches for development and approval.

Purpose of the Study:

  • To explore current research and development strategies for novel radioprotective agents.
  • To address the unmet need for safe, effective, and orally administered radioprotectants.
  • To discuss the potential of various approaches in the search for a new generation of radiation protection drugs.

Main Methods:

  • Review of ongoing research and development strategies for radioprotectants.

Related Experiment Videos

  • Exploration of chemical screening, drug reformulation, nutraceuticals, and combination therapies.
  • Consideration of strategies balancing efficacy with reduced toxicity and leveraging post-exposure treatments.

    • Main Results:

    • Multiple strategies are being pursued, including screening new compounds, reformulating existing drugs, and utilizing nutraceuticals.
    • Combination therapies and approaches prioritizing reduced toxicity over maximum efficacy are under investigation.
    • Increased interest and resources are driving innovation in radiation protection research.

    Conclusions:

    • The probability of developing a useful radioprotective agent is increasing due to diverse research efforts.
    • Federal agency support and FDA willingness to innovate are facilitating progress.
    • Continued research across multiple strategies holds promise for future radioprotection solutions.